Azenta (NASDAQ:AZTA) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Azenta (NASDAQ:AZTA) announced its earnings results on Wednesday. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03, Zacks reports. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%.

Azenta Stock Performance

Azenta stock opened at $54.04 on Friday. Azenta has a one year low of $38.82 and a one year high of $67.77. The stock’s fifty day moving average price is $50.49 and its two-hundred day moving average price is $49.10.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Stephens restated an “overweight” rating and set a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd. Evercore ISI boosted their price target on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research note on Thursday. Finally, Needham & Company LLC increased their price objective on Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research report on Thursday.

Insider Activity at Azenta

In related news, Director William L. Cornog bought 12,500 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were purchased at an average price of $39.60 per share, with a total value of $495,000.00. Following the completion of the purchase, the director now owns 14,755 shares in the company, valued at $584,298. This represents a 554.32 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Herman Cueto sold 712 shares of the company’s stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $40.07, for a total value of $28,529.84. Following the completion of the transaction, the chief financial officer now directly owns 23,892 shares of the company’s stock, valued at approximately $957,352.44. The trade was a 2.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,423 shares of company stock valued at $57,020 over the last quarter. 10.62% of the stock is owned by corporate insiders.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.